The superior laryngeal nerve block has rapidly gained popularity as an effective, minimally invasive intervention for managing laryngeal sensory neuropathies. Clinicians routinely utilize this localized procedural intervention to address refractory neurogenic cough, persistent paralaryngeal pain, and globus sensation. While practitioners consider the injection straightforward and well tolerated, rare adverse events can still emerge. Therefore, understanding the potential spectrum of unintended complications remains vital for safe clinical practice.

Indications and Clinical Utility of Superior Laryngeal Nerve Block

Laryngeal sensory neuropathy presents a unique diagnostic and therapeutic challenge. Consequently, standard antitussive medications and speech therapies often fail to deliver sustained relief. The superior laryngeal nerve block provides targeted therapy by interrupting hyperactive afferent neural pathways. Specifically, clinicians inject local anesthetic and corticosteroid near the internal branch of the superior laryngeal nerve. This branch traverses the thyrohyoid membrane to supply sensation to the supraglottic mucosa. Furthermore, in-office nerve blockade provides prompt diagnostic confirmation when patients exhibit paralaryngeal trigger points. Multiple clinical investigations confirm that this targeted technique achieves significant reductions in cough severity. In addition, patients suffering from irritable larynx syndrome frequently achieve enhanced phonatory comfort. Because the procedure avoids general anesthesia, otolaryngologists widely embrace it in daily practice. However, expanding clinical utilization inevitably exposes rare procedural complications that clinicians must recognize early.

Multi-Institutional Findings on Rare Adverse Events

A recent multi-institutional study evaluated uncommon complications following superior laryngeal nerve block across fifteen academic centers. Sixteen laryngologists contributed their procedural data, and ten clinicians documented rare adverse events among thirteen patients. Most patients in this cohort were women, with an average age of 57.2 years. The documented complications ranged from localized motor nerve deficits to unexpected systemic responses. Fortunately, researchers classified the vast majority of these adverse events as minor. When evaluated under the standardized Clavien-Dindo Scale of surgical complications, eleven of the thirteen cases represented grade I complications. These self-limiting events resolved spontaneously without secondary interventions. Only two conditions, specifically pyriform sinus fungal pharyngitis and adrenal suppression, warranted pharmacological treatment, earning a grade II classification. Consequently, these findings reaffirm that severe morbidity remains exceedingly rare while underscoring the necessity of structured post-procedure surveillance.

Neurovascular and Adjacent Nerve Involvement

Medication diffusion into adjacent cervical neural structures accounts for the most frequent complications identified in the multi-institutional series. Specifically, marginal mandibular nerve palsy occurred in five patients, making it the most common unexpected outcome. Practitioners likely induced this transient paresis when injectate migrated superiorly along fascial planes toward the submandibular space. Affected individuals experienced temporary lower lip asymmetry, which resolved completely as local anesthesia waned. Similarly, regional anesthetic spread produced transient Horner syndrome in one patient due to sympathetic chain blockade. Another patient developed hypoglossal nerve palsy, leading to temporary tongue deviation. In addition, two patients experienced transient ischemic attacks following injection. These vascular events likely stemmed from accidental intravascular penetration or reflex hemodynamic fluctuations. Therefore, clinicians must exercise meticulous precision, perform careful aspiration before injection, and maintain awareness of cervical neurovascular anatomy.

Systemic and Infectious Complications

Although the superior laryngeal nerve block primarily exerts local effects, systemic and infectious complications can occasionally manifest. In the multi-institutional study, two patients developed localized fungal pharyngitis involving the pyriform sinus. This infection occurred because corticosteroid infiltration suppresses mucosal immunity if the needle penetrates the pharyngeal lumen. Consequently, opportunistic fungal proliferation developed, requiring targeted oral antifungal therapy for full recovery. Moreover, clinicians documented one case of secondary adrenal suppression following corticosteroid administration. Exogenous steroid absorption can suppress hypothalamic-pituitary-adrenal function, particularly in susceptible patients receiving concurrent steroid treatments. Additionally, one patient suffered an anxiety-related vasovagal response immediately following injection. Practitioners must therefore obtain thorough pharmacological histories, assess baseline endocrine vulnerability, and monitor patients closely for delayed systemic symptoms or mucosal changes.

Anatomical Landmarks and Safe Injection Techniques

Preventing complications during a superior laryngeal nerve block requires a rigorous understanding of anterior neck anatomy. Clinicians palpate the greater cornu of the hyoid bone and the superior thyroid notch to identify the thyrohyoid membrane. The internal branch of the superior laryngeal nerve pierces this membrane anterior and inferior to the greater cornu. Practitioners introduce a fine 27-gauge needle perpendicular to the skin until encountering the elastic resistance of the membrane. However, anatomical variations or prior neck surgeries can distort tissue planes. Clinicians must aspirate in multiple planes prior to injecting medication to avoid inadvertent vascular puncture. Furthermore, practitioners should keep injection volumes relatively small, typically between one and two milliliters. This controlled volume prevents excess pressure and limits unintended fascial diffusion into neighboring tissues. When landmarks appear obscured, clinicians should consider ultrasound guidance.

Informed Consent and Risk Mitigation Strategies

Because superior laryngeal nerve blockade is an elective office procedure, comprehensive informed consent remains indispensable. Laryngologists should discuss common side effects, such as mild injection site ecchymosis, transient soreness, and temporary laryngeal numbness. In addition, clinicians must explicitly counsel patients regarding rare possibilities, including transient facial weakness, voice changes, or unexpected swallowing difficulties. Transparent pre-procedure communication alleviates patient anxiety and establishes realistic expectations. Furthermore, clinical teams must establish standardized post-injection monitoring protocols. Patients should remain seated in the clinic for fifteen to twenty minutes following injection to monitor for vasovagal reactions. Clinicians must advise patients to avoid hot beverages for two hours if laryngeal sensation diminishes. Ultimately, robust clinical education, rigorous anatomical targeting, and detailed documentation optimize procedural outcomes while safeguarding patient safety.

Frequently Asked Questions

What is a superior laryngeal nerve block and why is it performed?

A superior laryngeal nerve block is a minimally invasive in-office procedure designed to treat chronic laryngeal sensory neuropathies. Clinicians inject a localized combination of local anesthetic and corticosteroid near the internal branch of the superior laryngeal nerve. This treatment effectively relieves refractory neurogenic cough, paralaryngeal pain, and globus sensation by desensitizing hyperactive sensory afferent pathways when conventional therapies fail to provide relief.

How common are severe complications following this laryngeal injection?

Severe complications following this injection remain exceptionally rare. Multi-institutional data show that most adverse events are mild, self-limiting grade I complications that resolve without intervention, such as transient facial weakness or minor bruising. More serious grade II complications, including pyriform sinus fungal infections and adrenal suppression, occur infrequently but require targeted pharmacological treatment, highlighting the critical importance of careful patient selection and monitoring.

How can clinicians reduce the risk of adjacent nerve palsies during the block?

Clinicians can significantly minimize neighboring nerve paresis by strictly adhering to anatomical landmarks and controlling injectate volume. Practitioners should inject no more than one to two milliliters of medication and verify needle placement near the thyrohyoid membrane. Furthermore, meticulous aspiration before injection prevents intravascular delivery, while real-time ultrasound guidance offers valuable anatomical visualization whenever surface landmarks remain difficult to palpate.

Disclaimer: This content is for informational and educational purposes only and should not be considered as medical advice. Healthcare professionals should rely on their clinical judgment and verify details independently. Refer to the latest local and national guidelines for clinical practice.

References

Miller SM et al. Rare Complications Of A Popular Procedure: A Multi-institutional Case Series of Superior Laryngeal Nerve Block (SLN) Complications. J Voice. 2026 Aug 15. doi: undefined. PMID: 42603774.

Simpson CB, Amin MR. Treatment of chronic neurogenic cough with in-office superior laryngeal nerve block. Laryngoscope. 2018;128(8):1898-1903.

Dhillon VK, Akst LM. Superior Laryngeal Nerve Block for the Treatment of Neurogenic Cough: A Systematic Review and Clinical Perspective. J Voice. 2024;38(2):412-419.